591775-09-6

Basic information

• Product Name: 3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester
• Synonyms: 3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester
• CAS NO: 591775-09-6
• Molecular Formula: C₁₁H₁₄O₂S
• Molecular Weight: 210.29266
• EINECS: -0
• Mol File: 591775-09-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester(591775-09-6)
• EPA Substance Registry System: 3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester(591775-09-6)

Safety Data

• Hazardous Substances Data: 591775-09-6(Hazardous Substances Data)

Upstream product

• 591775-11-0 3-(4-dimethylcarbamoylsulfanyl-2-methyl-phenyl)-propionic acid methyl ester 

Downstream Products

• 1375007-29-6 3-(4-{1-[3-iodo-5-(4-trifluoromethyl-phenyl)-thiophen-2-yl]-ethylsulfanyl}-2-methyl-phenyl)-propionic acid methyl ester 
• 860007-85-8 methyl 3-{2-methyl-4-[1-(4-trifluoromethylphenyl)-1H-indazol-7-ylmethylsulfanyl]phenyl}propionate 

Relevant articles and documents

BICYCLIC DERIVATIVES AS PPAR MODULATORS

The present invention is directed to compounds represented by the following structural formula, Formula (I), and stereoisomers, pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) R2 is selected from the group consisting of C0-C8 alkyl and C1-4- heteroalkyl; (b) X is selected from the group consisting of a single bond, O, S, S(O)2 and N; (c) U is an aliphatic linker wherein one carbon atom of the aliphatic linker is optionally replaced with O, NH or S, and wherein such aliphatic linker is optionally substituted with from one to four substituents each independently selected from R30; (d) Y is selected from the group consisting of C, O, S, NH and a single bond; and (e) E is C(R3)(R4)A or A.

THIOPHENE DERIVATIVE PPAR MODULATORS

The present invention is directed to compounds represented by the following structural formula, Formula I: and stereoisomers, pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) X is selected from the group consisting of O, S, S(O)2, N, and a bond; (b) U is an aliphatic linker wherein one carbon atom of the aliphatic linker may be replaced with O, NH or S, and wherein such aliphatic linker is optionally substituted with R30; (c) Y is selected from the group consisting of C, O, S, NH and a single bond; and (d) E is C(R3)(R4)A or A.